Category: China Market Updates

Here’s the latest China regulatory and clinical affairs news for medical device and IVDs pros in August 2026. These updates are presented by China Med Device, LLC, your partner in

On March 24, 2026, NMPA published draft versions of registration review key points for 18 medical devices. Once finalized, the documents aim to provide manufacturers with clearer guidance on testing,

In 2025, polydeoxyribonucleotide (PDRN) has rapidly emerged as one of the most closely watched bioactive materials in the global skincare and medical aesthetics industry. Across international ingredient exhibitions, functional skincare

China has applied provisional import tariff rates lower than the most-favored-nation rates on 935 items starting from January 1, 2026, the Customs Tariff Commission of the China State Council announced

The Shanghai Municipal Medical Products Administration issued the “Provisions on Transferring Medical Devices with Existing Registration Certificates into Shanghai Production” on August 14, 2025. The regulation will take effect on

The NMPA National Institutes for Food and Drug Control released the draft GB/T 16886.1-2025, “Biological Evaluation of Medical Devices — Part 1: Evaluation and Testing Within a Risk Management Process”